A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The main purpose of this study is to evaluate how different dose levels of brenipatide work and how safe they are in healthy people with overweight or obesity. The study will assess the effects of different doses given as subcutaneous (under the skin) injections. Participation in this study will last about 42 weeks.
Epistemonikos ID: 265172150ca0f3f0e50142c1c76a4cc4bcbb5da4
First added on: Mar 18, 2026